A novel intermittent regimen of norgestimate to preserve the beneficial effects of 17β-estradiol on lipid and lipoprotein profiles

American Journal of Obstetrics and Gynecology

Volumn 182, Issue 1 I, 2000, Pages 41-49

  Lobo, R A ^a,b,c,d   Zacur, H Z ^a,b,c,d   Caubel, P ^a,b,c,d   Lane, R ^a,b,c,d  

^a Columbia Presbyterian Medical Center ^*

^b New York Presbyterian Hospital Columbia University Medical Center   (United States)

^c DEPARTMENT OF PATHOLOGY   (United States)

^d RW Johnson Pharmaceutical Research Institute   (United States)

Author keywords

17 Estradiol; Hormone replacement therapy; Lipids; Lipoproteins; Norgestimate

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; ESTRADIOL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NORGESTIMATE; ORTHO PREFEST; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; ESTROGEN THERAPY; FEMALE; HUMAN; ISCHEMIC HEART DISEASE; LIPID METABOLISM; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MULTICENTER STUDY; POSTMENOPAUSE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0033977845     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9378(00)70489-3     Document Type: Article

References (34)

1. American Heart Association 1997 Heart and stroke statistical update 1997 The Association Dallas
2. A Nasr M Breckwoldt Estrogen replacement therapy and cardiovascular protection: lipid mechanisms are the tip of an iceberg Gynecol Endocrinol 12 1998 43 59
3. G Samsioe Cardioprotection by estrogens: mechanisms of action—the lipids Int J Fertil Menopausal Stud 39 Suppl 1 1994 43 49
4. L Sourander T Rajala I Räiha J Mäkinen R Erkkola H Helenius Cardiovascular and cancer morbidity and mortality and sudden cardiac death in postmenopausal women on oestrogen replacement therapy (ERT) Lancet 352 1998 1965 1969
5. G Samsioe Cardiovascular disease in postmenopausal women Maturitas 30 1998 11 18
6. NK Wenger Postmenopausal hormone therapy. Is it useful for coronary prevention? Cardiol Clin 16 1998 17 25
7. T O’Brien TT Nguyen Lipids and lipoproteins in women Mayo Clin Proc 72 1997 235 244
8. MJ Tikkanen The menopause and hormone replacement therapy: lipids, lipoproteins, coagulation and fibrinolytic factors Maturitas 23 1996 209 216
9. DA Shewmon Lipids, atherosclerosis, and the postmenopausal woman: a clinical perspective Obstet Gynecol Clin North Am 21 1994 337 355
10. RA Lobo Clinical review 27: Effects of hormonal replacement on lipids and lipoproteins in postmenopausal women J Clin Endocrinol Metab 73 1991 925 930
11. MI Whitehead RJ King J McQueen S Campbell Endometrial histology and biochemistry in climacteric women during oestrogen and oestrogen/progestogen therapy J R Soc Med 72 1979 322 327
12. DW Sturdee T Wade-Evans ME Paterson M Thom JW Studd Relations between bleeding pattern, endometrial histology, and oestrogen treatment in menopausal women BMJ 1 1978 1575 1577
13. MI Whitehead The effects of oestrogens and progestogens on the postmenopausal endometrium Maturitas 1 1978 87 98
14. I Persson HO Adami L Bergkvist A Lindgren B Pettersson R Hoover Risk of endometrial cancer after treatment with oestrogens alone or in conjunction with progestogens: results of a prospective study BMJ 298 1989 147 151
15. I Schiff HK Sela D Cramer D Tulchinsky KJ Ryan Endometrial hyperplasia in women on cyclic or continuous estrogen regimens Fertil Steril 37 1982 79 82
16. DB Williams KH Moley Progestin replacement in the menopause: effects on the endometrium and serum lipids Curr Opin Obstet Gynecol 6 1994 284 292
17. TR Varma Effect of long-term therapy with estrogen and progesterone on the endometrium of post-menopausal women Acta Obstet Gynecol Scand 64 1985 41 46
18. MH Thom PJ White RM Williams DW Sturdee ME Paterson T Wade-Evans Prevention and treatment of endometrial disease in climacteric women receiving oestrogen therapy Lancet 2 1979 455 457
19. FM Sacks M Gerhard BW Walsh Sex hormones, lipoproteins, and vascular reactivity Curr Opin Lipidol 6 1995 161 166
20. AH Rijpkema AA van der Sanden AH Ruijs Effects of post-menopausal oestrogen-progestogen replacement therapy on serum lipids and lipoproteins: a review Maturitas 12 1990 259 285
21. RF Casper A Chapdelaine Estrogen and interrupted progestin: a new concept for menopausal hormone replacement therapy Am J Obstet Gynecol 168 1993 1188 1194
22. PJ Sulak P Caubel R Lane Efficacy and safety of a constant estrogen, pulsed progestin regimen in hormone replacement therapy Int J Fertil Womens Med 1999 In press
23. P Caubel PC Lim G Creasy Effect on 17b-estradiol/norgestimate cyclophasic hormone replacement therapy on endometrial histology [abstract] Obstet Gynecol 93 Suppl 4 1999 81S
24. SL Corson Norgestimate Clin Obstet Gynecol 38 1995 841 848
25. WT Friedewald RI Levy DS Fredrickson Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge Clin Chem 18 1972 499 502
26. RA Lobo M Notelovitz L Bernstein FY Khan RK Ross WL Paul Lp(a) lipoprotein: relationship to cardiovascular disease risk factors, exercise, and estrogen Am J Obstet Gynecol 166 1992 1182 1190
27. JW Rich-Edwards JE Manson CH Hennekens JE Buring The primary prevention of coronary heart disease in women N Engl J Med 332 1995 1758 1766
28. DJ Gordon JL Probstfield RJ Garrison JD Neaton WP Castelli JD Knoke High-density lipoprotein cholesterol and cardiovascular disease: four prospective American studies Circulation 79 1989 8 15
29. Summary of the second report of the National Cholesterol Education Program NCEP Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II) JAMA 269 1993 3015 3023
30. JH Stein RS Rosenson Lipoprotein Lp(a) excess and coronary heart disease Arch Intern Med 157 1997 1170 1176
31. AM Gotto Jr Triglyceride as a risk factor for coronary artery disease Am J Cardiol 82 1998 22Q 25Q
32. G Assmann H Schulte H Funke A von Eckardstein The emergence of triglycerides as a significant independent risk factor in coronary artery disease Eur Heart J 19 Suppl M 1998 M8 M14
33. SL Corson Efficacy and safety of a monophasic and a triphasic oral contraceptive containing norgestimate Am J Obstet Gynecol 170 1994 1556 1561
34. J Haarbo C Hassager SB Jensen BJ Riis C Christiansen Serum lipids, lipoproteins, and apolipoproteins during postmenopausal estrogen replacement therapy combined with either 19-nortestosterone derivatives or 17-hydroxyprogesterone derivatives Am J Med 90 1991 584 589